Christopher Garris

7.3k total citations · 4 hit papers
33 papers, 3.3k citations indexed

About

Christopher Garris is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Christopher Garris has authored 33 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Christopher Garris's work include Immune cells in cancer (17 papers), Immunotherapy and Immune Responses (11 papers) and Immune Cell Function and Interaction (10 papers). Christopher Garris is often cited by papers focused on Immune cells in cancer (17 papers), Immunotherapy and Immune Responses (11 papers) and Immune Cell Function and Interaction (10 papers). Christopher Garris collaborates with scholars based in United States, Switzerland and France. Christopher Garris's co-authors include Mikäel J. Pittet, Ralph Weissleder, Michael F. Cuccarese, Sean P. Arlauckas, Rainer H. Köhler, Christopher B. Rodell, Maaz S. Ahmed, Ran Li, Miles A. Miller and Christina Pfirschke and has published in prestigious journals such as Science, Cell and Journal of the American Chemical Society.

In The Last Decade

Christopher Garris

33 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

2018 867 citations Christopher B. Rodell, Sean P. Arlauckas et al. Nature Biomedical Engineering profile →
In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy

2017 504 citations Sean P. Arlauckas, Christopher Garris et al. Science Translational Medicine profile →
A neutrophil response linked to tumor control in immunotherapy

2023 229 citations Jeremy Gungabeesoon, Nicolas A. Gort-Freitas et al. Cell profile →
Dendritic cells as shepherds of T cell immunity in cancer

2023 142 citations Mikäel J. Pittet, Mauro Di Pilato et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Garris United States	20	2.0k	1.1k	1.1k	778	291	33	3.3k
Sean P. Arlauckas United States	12	1.4k 0.7×	851 0.8×	694 0.6×	613 0.8×	221 0.8×	17	2.3k
Alex D. Waldman United States	7	1.5k 0.7×	955 0.8×	1.6k 1.4×	480 0.6×	258 0.9×	14	3.0k
Christina Pfirschke United States	18	2.5k 1.2×	1.4k 1.2×	1.8k 1.6×	824 1.1×	451 1.5×	20	4.3k
Yoko Oei United States	12	1.9k 1.0×	1.4k 1.2×	1.1k 1.0×	353 0.5×	338 1.2×	17	3.6k
Viviana Cremasco United States	22	1.4k 0.7×	1.2k 1.1×	1.6k 1.4×	418 0.5×	469 1.6×	31	3.3k
Roy Noy Israel	12	2.7k 1.3×	1.3k 1.2×	1.8k 1.6×	421 0.5×	590 2.0×	20	3.9k
Oakley C. Olson United States	18	2.3k 1.1×	1.3k 1.2×	1.5k 1.3×	342 0.4×	702 2.4×	23	4.2k
Laura Conti Italy	31	901 0.4×	961 0.8×	723 0.6×	268 0.3×	396 1.4×	88	2.5k
Carola H. Ries Germany	25	2.0k 1.0×	1.3k 1.2×	1.7k 1.5×	422 0.5×	525 1.8×	38	3.7k
G‐One Ahn South Korea	24	666 0.3×	838 0.7×	868 0.8×	337 0.4×	455 1.6×	44	2.4k

Countries citing papers authored by Christopher Garris

Since Specialization

Citations

This map shows the geographic impact of Christopher Garris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Garris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Garris more than expected).

Fields of papers citing papers by Christopher Garris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Garris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Garris. The network helps show where Christopher Garris may publish in the future.

Co-authorship network of co-authors of Christopher Garris

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Garris. A scholar is included among the top collaborators of Christopher Garris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Garris. Christopher Garris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garris, Christopher, Eliana Marinari, Juhyun Oh, et al.. (2025). Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence. Nature Biomedical Engineering. 1 indexed citations

Qin, Tingting, Austin K. Mattox, Jean S. Campbell, et al.. (2025). Epigenetic therapy sensitizes anti–PD-1 refractory head and neck cancers to immunotherapy rechallenge. Journal of Clinical Investigation. 135(6). 5 indexed citations

Fei, Fan, et al.. (2025). Fluorinated Ribonucleocarbohydrate Nanoparticles Allow Ultraefficient mRNA Delivery and Protein Expression in Tumor-Associated Myeloid Cells. Journal of the American Chemical Society. 147(14). 11766–11776. 3 indexed citations

Parvanian, Sepideh, et al.. (2025). Recent developments in myeloid immune modulation in cancer therapy. Trends in cancer. 11(4). 365–375. 2 indexed citations

Goubet, Anne‐Gaëlle, et al.. (2024). Pharmacological Polarization of Tumor‐Associated Macrophages Toward a CXCL9 Antitumor Phenotype. Advanced Science. 11(15). e2309026–e2309026. 7 indexed citations

Sarkar, Biplab, Sean P. Arlauckas, Michael F. Cuccarese, et al.. (2024). Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotype. Frontiers in Immunology. 15. 1331480–1331480. 2 indexed citations

Chen, Chang-Yu, Sarah A. Weiss, Kazuhiro Taguchi, et al.. (2024). The aged tumor microenvironment limits T cell control of cancer. Nature Immunology. 25(6). 1033–1045. 43 indexed citations

Garris, Christopher, Rainer H. Köhler, Yoshiko Iwamoto, et al.. (2024). Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes. Advanced Science. 12(4). e2410360–e2410360. 8 indexed citations

Pittet, Mikäel J., Mauro Di Pilato, Christopher Garris, & Thorsten R. Mempel. (2023). Dendritic cells as shepherds of T cell immunity in cancer. Immunity. 56(10). 2218–2230. 142 indexed citations breakdown →

10.

Gungabeesoon, Jeremy, Nicolas A. Gort-Freitas, Máté Kiss, et al.. (2023). A neutrophil response linked to tumor control in immunotherapy. Cell. 186(7). 1448–1464.e20. 229 indexed citations breakdown →

11.

Oh, Juhyun, Rainer H. Köhler, Hannah Peterson, et al.. (2022). Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti‐Tumor Immunity in Murine Glioblastoma. Advanced Materials. 35(7). e2208782–e2208782. 33 indexed citations

12.

Deyell, Matthew, Christopher Garris, & Ashley M. Laughney. (2021). Cancer metastasis as a non-healing wound. British Journal of Cancer. 124(9). 1491–1502. 64 indexed citations

13.

Lan, Yuk Yuen, James Heather, Thomas Eisenhaure, et al.. (2019). Extranuclear DNA accumulates in aged cells and contributes to senescence and inflammation. Aging Cell. 18(2). e12901–e12901. 95 indexed citations

14.

Liao, Hsin-Wei, Christopher Garris, Christina Pfirschke, et al.. (2019). LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects. SHILAP Revista de lepidopterología. 3(11). 348–360. 24 indexed citations

15.

Rodell, Christopher B., Maaz S. Ahmed, Christopher Garris, Mikäel J. Pittet, & Ralph Weissleder. (2019). Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy. Theranostics. 9(26). 8426–8436. 76 indexed citations

16.

Arlauckas, Sean P., Christopher Garris, Rainer H. Köhler, et al.. (2017). In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy. Science Translational Medicine. 9(389). 504 indexed citations breakdown →

17.

Pucci, Ferdinando, Christopher Garris, Charles Pin‐Kuang Lai, et al.. (2016). SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions. Science. 352(6282). 242–246. 258 indexed citations

18.

Garris, Christopher, Linfeng Wu, Swati Acharya, et al.. (2013). Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nature Immunology. 14(11). 1166–1172. 131 indexed citations

19.

Misaghi, Shahram, Christopher Garris, Yonglian Sun, et al.. (2010). Increased Targeting of Donor Switch Region and IgE in Sγ1-Deficient B Cells. The Journal of Immunology. 185(1). 166–173. 14 indexed citations

20.

Hackney, Jason A., Shahram Misaghi, Kate Senger, et al.. (2009). Chapter 5 DNA Targets of AID. Advances in immunology. 101. 163–189. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact